Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.
Mono-allelic germline mutations in mismatch repair (MMR) genes lead to Lynch syndrome, an autosomal dominant syndrome with an increased risk of predominantly colorectal and endometrial cancers. Bi-allelic germline mutations in MMR genes predispose to haematological malignancies, brain tumours, gastrointestinal tumours, polyposis and features of neurofibromatosis type 1 in early childhood.We report a brother and a sister with bi-allelic germline mutations in MSH2; a pathogenic deletion of the first 6 exons and a variant of the initiation codon (c.1A>G (p.Met1?)), whereas their phenotypes (four colorectal cancers, small bowel carcinoma and 15 adenomas at age 39 and 48, and colorectal cancer, endometrial cancer and four adenomas at age 33 and 44, respectively) are more suggestive of a mono-allelic pathogenic MMR gene mutation. The carcinomas showed microsatellite instability in the presence of MLH1, PMS2, MSH2 and MSH6 proteins, indicating that the variant c.1A>G leads to an alternative protein with reduced activity that is retained in the tumours.Our data suggest that the MSH2 variant c.1A>G (p.Met1?) should not be considered as a regular pathogenic mutation that leads to a strongly increased cancer risk, though it possibly contributes to a more severe phenotype when combined with a truncating mutation on the other allele.
Kets
Carolien M
CM
Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. m.kets@antrg.umcn.nl
Hoogerbrugge
Nicoline
N
van Krieken
Joannes H J M
JH
Goossens
Monique
M
Brunner
Han G
HG
Ligtenberg
Marjolijn J L
MJ
D000328:Adult; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000235:genetics; D005260:Female; D017353:Gene Deletion; D006579:Heterozygote; D006801:Humans; D008297:Male; D053842:Microsatellite Instability; D051718:MutS Homolog 2 Protein / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics*; D010375:Pedigree; D017354:Point Mutation
C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein
Br J Cancer. 2007 May 21;96(10):1605-12
17453009
Clin Genet. 2007 Jun;71(6):499-500
17539898
Fam Cancer. 2001;1(2):101-5
14574005
Am J Hum Genet. 2003 May;72(5):1088-100
12658575
Clin Genet. 2007 Jun;71(6):483-98
17539897
Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):91-9
15264277
Am J Hum Genet. 2004 May;74(5):954-64
15077197
Cell. 1986 Jan 31;44(2):283-92
3943125
J Pathol. 2005 Dec;207(4):385-95
16216036
Br J Cancer. 2006 Dec 18;95(12):1678-82
17117178
Cancer Res. 2002 Jan 15;62(2):359-62
11809679
Clin Genet. 2003 Jan;63(1):64-70
12519374
Hum Mutat. 2000;16(1):61-7
10874307
Cancer Res. 1998 Nov 15;58(22):5248-57
9823339
N Engl J Med. 2003 Mar 6;348(10):919-32
12621137
Nature. 2000 Oct 12;407(6805):711-7
11048711
Am J Med Genet A. 2005 Dec 1;139A(2):96-105; discussion 96
16283678
Gastroenterology. 2007 Feb;132(2):527-30
17258725
Am J Hum Genet. 1998 Sep;63(3):749-59
9718327
Hum Genet. 2003 Feb;112(2):117-23
12522551
Dis Markers. 2004;20(4-5):251-7
15528790
N Engl J Med. 1995 Mar 30;332(13):839-47
7661930
Am J Hum Genet. 2003 Jan;72(1):213-6
12549480
N Engl J Med. 2006 Jun 29;354(26):2751-63
16807412
Oncogene. 2000 Mar 23;19(13):1719-23
10763829